The global scleroderma therapeutics market size was valued at USD 2.53 billion in 2024 and is projected to reach USD 3.94 billion by 2032, with a CAGR of 5.7% during the forecast period of 2025 to 2032.
You must login to leave a comment.
No comments yet. Be the first to comment!
Leave a Comment
You must login to leave a comment.
Comments (0)
No comments yet. Be the first to comment!